Glucagon-like Peptide 1-Based Drugs and Pancreatic Safety

被引：1
作者：
Raschi, Emanuel [1 ]
Piccinni, Carlo [1 ]
Marchesini, Giulio [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 19期
关键词：
RISK;
D O I：
10.1001/jamainternmed.2013.8150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1843
页数：1
相关论文
共 50 条
  • [21] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    Faurschou, A.
    Knop, F. K.
    Thyssen, J. P.
    Zachariae, C.
    Skov, L.
    Vilsboll, T.
    ACTA DIABETOLOGICA, 2014, 51 (01) : 147 - 150
  • [22] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
    Wang, Wenwen
    Mei, Aihua
    Qian, Hang
    Li, Dongfeng
    Xu, Hao
    Chen, Jishun
    Yang, Handong
    Min, Xinwen
    Li, Chunlei
    Cheng, Li
    Chen, Jun
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 129 - 137
  • [23] Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database
    Wu, Tingxi
    Zhang, Yang
    Shi, Yanfeng
    Yu, Kefu
    Zhao, Mei
    Liu, Shangyi
    Zhao, Zhigang
    CLINICAL DRUG INVESTIGATION, 2022, 42 (11) : 965 - 975
  • [24] Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process
    Hachula, Marcin
    Kosowski, Michal
    Ryl, Sabina
    Basiak, Marcin
    Okopien, Boguslaw
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [25] Suicidality among users of glucagon-like peptide-1 receptor agonists: An emerging signal?
    Lau, Darren
    Gamble, John-Michael
    DIABETES OBESITY & METABOLISM, 2024, 26 (04) : 1150 - 1156
  • [26] Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients
    Singh, Sahib
    Garg, Aakash
    Tantry, Udaya S.
    Bliden, Kevin
    Gurbel, Paul A.
    Gulati, Martha
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (03)
  • [27] Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
    Butler, P. C.
    Matveyenko, A. V.
    Dry, S.
    Bhushan, A.
    Elashoff, R.
    DIABETOLOGIA, 2010, 53 (01) : 1 - 6
  • [28] Patient education and monitoring recommendations for the use of glucagon-like peptide-1 receptor agonists
    Haines, Stuart T.
    JOURNAL OF FAMILY PRACTICE, 2009, 58 (09) : S44 - S48
  • [29] Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
    Yen, Fu-Shun
    Hsu, Chih-Cheng
    Wei, James Cheng-Chung
    Tsai, Fuu-Jen
    Huang, Yuhan
    Yu, Teng-Shun
    Hwu, Chii-Min
    THORAX, 2024, 79 (11) : 1017 - 1023
  • [30] Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load
    Sasaki, Yu
    Abe, Yasuhiko
    Takeda, Hiroaki
    Nishise, Shoichi
    Yaoita, Takao
    Yagi, Makoto
    Sakuta, Kazuhiro
    Mizumoto, Naoko
    Shoji, Masakuni
    Onozato, Yusuke
    Kawata, Sumio
    Ueno, Yoshiyuki
    DIGESTION, 2018, 97 (04) : 324 - 332
12345